Teva Pharmaceutical Industries Earnings Date, Estimates & History

-0.11 (-0.99 %)
(As of 06/14/2021 01:56 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume137,588 shs
Average Volume6.62 million shs
Market Capitalization$12.01 billion
P/E RatioN/A
Dividend YieldN/A

Teva Pharmaceutical Industries (NYSE:TEVA) Earnings Information

Teva Pharmaceutical Industries last issued its earnings results on April 28th, 2021. The reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.55 by $0.08. The company earned $3.98 billion during the quarter, compared to the consensus estimate of $4.04 billion. Its revenue was down 8.6% on a year-over-year basis. Teva Pharmaceutical Industries has generated $2.45 earnings per share over the last year. Teva Pharmaceutical Industries has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 4th, 2021 based off prior year's report dates.

Teva Pharmaceutical Industries Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Teva Pharmaceutical Industries (NYSE:TEVA) Earnings Estimates

2021 EPS Consensus Estimate: $2.49
2022 EPS Consensus Estimate: $2.56
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20213$0.54$0.61$0.57 
Q2 20214$0.54$0.58$0.55 
Q3 20214$0.63$0.69$0.66 
Q4 20214$0.68$0.76$0.71 
Q1 20221$0.61$0.61$0.61 
Q2 20221$0.62$0.62$0.62 
Q3 20221$0.66$0.66$0.66 
Q4 20221$0.67$0.67$0.67 

Teva Pharmaceutical Industries (NYSE TEVA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
4/28/20213/31/2021$0.55$0.63$1.13$4.04 billion$3.98 billionTranscript
2/10/202112/31/2020$0.63$0.68$1.14$4.37 billion$4.45 billionTranscript
11/5/20209/30/2020$0.58$0.58$5.09$4.09 billion$4.00 billionTranscript
8/5/20206/30/2020$0.53$0.55$0.91$3.94 billion$3.87 billionTranscript
5/7/20203/31/2020$0.59$0.76$1.40$4.15 billion$4.36 billionTranscript
2/12/202012/31/2019$0.61$0.62$1.12$4.35 billion$4.47 billionTranscript
11/7/2019Q3 2019$0.58$0.56$1.41$4.25 billion$4.26 billionTranscript
8/7/20196/30/2019$0.55$0.57$1.77$4.25 billion$4.34 billionListen
5/2/20193/31/2019$0.55$0.57$1.24$4.38 billion$4.30 billionListen
2/13/201912/31/2018$0.53$0.53$3.95$4.52 billion$4.56 billionN/A
11/1/20189/30/2018$0.53$0.64$1.55$4.54 billion$4.53 billionN/A
8/2/20186/30/2018$0.64$0.78$1.74$4.75 billion$4.70 billionN/A
5/3/20183/31/2018$0.63$0.91$0.79$4.80 billion$5.07 billionN/A
2/8/2018Q4 17$0.77$0.91$13.23$5.29 billion$5.46 billionTranscript
11/2/2017Q3 2017$1.03$0.95$1.38$5.61 billion$5.61 billionN/A
8/3/20176/30/2017$1.06$0.99$7.92$5.72 billion$5.69 billionListen
5/11/2017Q1 17$1.06$1.06$1.49$5.69 billion$5.63 billionN/A
2/13/2017Q4 2016$1.32$1.36$3.82$6.26 billion$6.25 billionN/A
11/15/2016Q3 2016$1.28$1.28$2.21$5.71 billion$5.56 billionN/A
8/4/2016Q2 2016$1.18$1.25$2.30$4.86 billion$5.00 billionN/A
5/9/2016Q1 2016$1.13$1.18$1.74$4.78 billion$4.81 billionN/A
2/11/2016Q4 2015$1.28$1.28$2.01$4.83 billion$4.88 billionListen
10/29/2015Q3 2015$1.29$1.35$2.58$4.75 billion$4.80 billionListen
7/30/2015Q2 2015$1.31$1.43$2.23$4.90 billion$4.97 billionListen
4/30/2015Q1 2015$1.26$1.36$2.20$4.84 billion$5.00 billionN/A
2/5/2015Q4 2014$1.30$1.31$1.82$5.17 billion$5.17 billionN/A
10/30/2014Q3 2014$1.23$1.32$1.62$5.09 billion$5.06 billionN/A
7/31/2014Q2 2014$1.22$1.23$1.59$5.08 billion$5.00 billionN/A
5/1/2014Q1 2014$1.23$1.22$1.57$5.11 million$5.00 billionTranscript
2/6/2014Q4 2013$1.40$1.42$2.39$5.19 billion$5.40 billionN/A
10/31/2013Q3 2013$1.26$1.27$1.70$5.00 billion$5.06 billionTranscript
8/1/2013Q2 2013$1.18$1.20$2.93$4.94 billion$4.90 billionTranscript
5/2/2013Q1 2013$1.10$1.12$1.50$4.85 billion$4.90 billionTranscript
2/7/2013Q412$1.33$1.32$5.26 billion$5.20 billionTranscript
11/1/2012Q312$1.25$1.28$5.08 billion$5.00 billionN/A
11/2/2010Q3 2010$1.27$1.30$1.45N/A
7/26/2010Q2 2010$1.04$1.08$1.28N/A
5/4/2010Q1 2010$0.89$0.92$1.05N/A
2/16/2010Q4 2009$0.95$0.94$1.46N/A
11/3/2009Q3 2009$0.88$0.89$1.06N/A
7/28/2009Q2 2009$0.80$0.83$1.08N/A
5/5/2009Q1 2009$0.67$0.72$0.93N/A
2/17/2009Q4 2008$0.73$0.76$2.40N/A
11/6/2008Q3 2008$0.69$0.72$0.67N/A
7/29/2008Q2 2008$0.64$0.65$0.65N/A
5/6/2008Q1 2008$0.63$0.64$1.10N/A
2/12/2008Q4 2007$0.66$0.69$0.69N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.